TP53 and acute myeloid leukemia: And numerous studies also showed PROTAC drugs are more efficient than the original antagonist.[25] MOLM‐13 is an acute myeloid leukemia cell line that overexpresses wild‐type p53 and MDM2 but lacks the Philadelphia chromosome.